Related Experiment Videos
In vitro selection analysis of trans-acting HDV ribozyme
F Nishikawa1, A Chiba, M Shirai
1National Institute of Bioscience and Human Technology, AIST, MITI, Tsukuba Science City, Japan.
Nucleic Acids Symposium Series
|January 1, 1995
Summary
Researchers identified new active variants of the human hepatitis delta virus (HDV) ribozyme using in vitro selection. The study revealed conserved structures and sequences, with mutations favoring anti-genomic-like patterns for optimal activity.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- The human hepatitis delta virus (HDV) possesses a unique trans-acting genomic ribozyme essential for its replication.
- Understanding the functional structure and variants of this ribozyme is crucial for deciphering viral mechanisms.
Purpose of the Study:
- To identify novel active variants of the HDV trans-acting genomic ribozyme.
- To elucidate the functional secondary structure of the HDV ribozyme.
Main Methods:
- In vitro selection procedures were employed over 10 generations.
- Analysis of the resulting randomized pool of trans-acting ribozymes.
Main Results:
- A conserved pseudoknot secondary structure was identified in the selected ribozymes.
- Key bases in single-stranded regions were found to be highly conserved.
- Mutated ribozymes showed a shift towards anti-genomic-like sequences.
- The most active variant demonstrated optimal nucleotide selection at each position.
Conclusions:
- The study successfully identified highly active HDV ribozyme variants.
- The findings confirm the pseudoknot model and highlight the importance of specific nucleotide conservation.
- Sequence evolution towards anti-genomic-like forms enhances ribozyme activity.